Results 91 to 100 of about 43,207 (322)

Timing and duration of glucagon‐like peptide‐1 receptor agonist use and risk of nonarteritic anterior ischaemic optic neuropathy

Acta Ophthalmologica, EarlyView.
Abstract Purpose To investigate the association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) use and nonarteritic anterior ischaemic optic neuropathy (NAION) in type 2 diabetes, examining treatment recency and cumulative duration. Methods This nationwide registry‐based nested case–control study utilizedz Danish health registries (1996 ...
Siar Niazi, Filip Gnesin, Baker Nawfal Jawad, Zia Niazi, Puriya Daniel Wuertz Yazdanfard, Anne P. Toft‐Petersen, Kathrine Kold Sørensen, Amani Meaidi, Yousif Subhi, Christian Torp‐Pedersen   +9 more
wiley   +1 more source

Improvement of diabetic microangiopathy with pycnogenol : a prospective,controlled study [PDF]

, 2006
The aim of this study was to investigate the clinical efficacy of oral Pycnogenol® (Horphag Research Ltd, United Kingdom) in patients with diabetic microangiopathy. Patients without a history of diabetic ulcerations were treated with Pycnogenol. Patients
F. Fano, A. Rizzi, M. Corsi, Ricci, A., G. Gizzi, G. Del Boccio, Pellegrini, L., Fano, F., Di Renzo, A., G. Belcaro, Ledda, A., A. Ledda, L. Pellegrini, G. Vinciguerra, Corsi, M., M. Cacchio, Rohdewald, P., Acerbi, G., Cipollone, G., Cesarone, M. R., P. Rohdewald, Belcaro, G., G. Acerbi, M. R. Cesarone, S. Stuard, Ippolito, E., G. Cipollone, Dugall, M., E. Ippolito, A. Di Renzo, M. Dugall, Vinciguerra, G., Stuard, S., Cacchio, M., Del Boccio, G., Gizzi, G.   +35 more
core   +1 more source

Thrombotic microangiopathy in allogeneic stem cell transplantation in childhood [PDF]

, 2010
PubMedID: 20716043Objectives: We define the incidence, risk factors, and mortality rates for the occurrence of thrombotic microangiopathy in 50 children who underwent transplants between January 2006 and June 2008 at 2 Turkish pediatric centers ...
Tanyeli A., Erbey F., Yilmaz S., Cetin M., Bayram I., Uckan D., Kuskonmaz B.   +6 more
core   +2 more sources

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies

British Journal of Haematology, EarlyView.
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi, Nandakumar Natarajan, Kathryn E. Dickerson, Richard A. Voit   +3 more
wiley   +1 more source

Cyclosporin-associated thrombotic microangiopathy: Successful retreatment with cyclosporin. Ren Fail [PDF]

, 1991
This report describes a patient whlo developed cyclosporin-induced thirombotic microangiopathy in a renal allograft. Cyclospolrin-induced thrombotic microangiopathy is considered by many as a contraindication to subsequent therapy with cyclosporin.
MD J Charles Jernnette, MD Stanley R Mandel, MD Paul Bolin Jr   +2 more
core  

Gemcitabine-induced thrombotic microangiopathy [PDF]

, 2013
Thrombotic microangiopathy (TMA) is a microvascular occlusive disorder characterised by platelet aggregation, thrombocytopenia and end-organ damage. It is commonly idiopathic, although several drug classes, including cytotoxic chemotherapy, have been ...
Abro, E., Gilbar, P., Richmond, J.
core   +1 more source

The Complement System in Post‐Transplant Kidney Injury

Organ Medicine, EarlyView.
Mengsi Hu
wiley   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Primary Thrombotic Microangiopathy in Pediatric Patients [PDF]

Background . Primary thrombotic microangiopathy includes hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli , atypical hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Methodology .
Lina María Martínez Sánchez MSc, Ana Paulina Pamplona Sierra MD, Daniela Vergara Yánez MD, Richard Baquero Rodriguez MD, Liliana Franco Hincapié PhD, Andrés David Aranzazu Ceballos MD   +5 more
core   +1 more source

Pathohistological features of lung tissue in patients with combined tuberculosis and diabetes mellitus

Infusion & Chemotherapy
BACKGROUND. Pathomorphological changes in the lungs in tuberculosis are complex and multi-stage. They range from the formation of granulomas and necrotic processes to the development of caverns and fibrosis, collectively leading to a complex of ...
I.O. Semianiv, L.D. Todoriko, V.I. Slivka, V.I. Stefanchuk   +3 more
doaj   +1 more source